FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, today announced that Erin Quirk, M.D., Chief Medical Officer, will present a corporate overview and update on the Company’s lead clinical programs at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020. Terns will present at 4:30 pm ET (1:30 p.m. PT) on June 2.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of drug candidates for the treatment of non-alcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), and cancer, across multiple modalities. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development in order to bring promising new therapies to patients.
For more information, visit www.ternspharma.com and www.ternspharma.com.cn.
Contacts
US Media Contact:
Margaret Robinson
(415) 690-0084
China Media Contact:
Zhou Zhou
+86 13482103703
Key takeaways:Gurnoor Brar has been added to India's ODI squad for the third West Indies…
Key takeaways:WCL 2026 has started with the INDCH vs AUSCH opening match.Vauve Global now owns…
Key takeaways:Abhishek Sharma has matched a major Yuvraj Singh record against Pakistan, according to The…
Key takeaways:Drishyam 3 opened as the biggest opener ever for Ajay Devgn, according to news…
Key takeaways:The India national cricket team vs West Indies cricket team rivalry shifted from Caribbean…
Key takeaways:India lost two early wickets in the 3rd ODI, with Virat Kohli dismissed for…